HDAC4 and AL amyloidosis: Recently, accumulating evidence has shown that HDAC4 overexpression is correlated with the development and progression of cancers, including multiple myeloma, prostate cancer, breast cancer, colon cancer, glioblastoma, and esophageal cancer9–14.